OXPHOS defects and mitochondrial DNA mutations in cardiomyopathy

Area of Science:

• Cardiology
• Mitochondrial Biology
• Genetics

Background:

• Mitochondrial respiratory chain defects are an underrecognized cause of heart failure.
• Infants with idiopathic hypertrophic cardiomyopathy often show reduced activity of respiratory chain complexes I or IV.

Purpose of the Study:

• To investigate the pathogenicity of a specific mitochondrial DNA (mtDNA) mutation (A3260G in tRNALeu(UUR)) associated with cardiomyopathy.
• To establish a controlled experimental system for studying mtDNA mutation effects on cardiac function.

Main Methods:

• Analysis of endocardial biopsies from infants with hypertrophic cardiomyopathy.
• Creation of transmitochondrial cybrid cell lines by fusing mutant cytoplasts with mtDNA-less cells.
• Assessment of respiratory chain complex activities, oxygen consumption, lactate production, and mtDNA-specific translation in cybrid clones.

Main Results:

• Reduced activity of mitochondrial respiratory chain complexes I and IV was observed in infant biopsies.
• Cybrid clones with near-homoplasmic A3260G mutation showed significantly decreased complex I and IV activity (63% and 67% of wild-type).
• Mutant cybrids exhibited impaired oxygen consumption (36% of wild-type) and increased lactate production (218% of wild-type), with defective mtDNA-specific translation.

Conclusions:

• The A3260G mtDNA mutation significantly impairs mitochondrial function and contributes to cardiomyopathy.
• Transmitochondrial cybrid models are effective for studying the pathogenicity of mtDNA mutations.
• Targeting mitochondrial dysfunction may offer new therapeutic strategies for heart failure.